Tofacitinib metabolite M2(1243290-37-0)
- Name: Tofacitinib metabolite M2
- Synonyms:CP-690550A;Tofacitinib metabolite M2;UNII-Q7ZOK859UK;Q7ZOK859UK;CP-690,550A;1243290-37-0;CP 690550A;CHEMBL1630791;2-Hydroxy-1-(4-methyl-3-(methyl-(7hpyrrolo(2,3-d)pyrimidin-4-yl)-amino)-piperidin-1-yl)-ethanone;PFE-PKIS 34;BDBM50332592;AKOS040751298;Q27287093;cis-2-Hydroxy-1-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone
- Molecular Formula:C15H21N5O2
- Molecular Weight:303.36
- CAS Registry Number:1243290-37-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1243290-37-0 Tofacitinib Impurity 123
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
CAS No.1243290-37-0 CP-690550A
Assay:98% Appearance:Powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:This active molecular is a novel Janus Kinase 3 (JAK3) inhibitor. CP-690550A is an immunosuppressant for the treatment of rheumatoid arthritis, psoriasis, transplant rejection and other immune-med...
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 252351-96-5/Lucidal
- 5430-90-0/Phosphoric acid--7-chloro-N-(3-{[2-(diethylamino)ethyl]sulfanyl}propyl)-3-methylquinolin-4-amine (1/1)
- 29165-36-4/8,10,21-Trichloro-5,5,13,13,18-pentamethyl-18-aza-5,13-diazoniatetracyclo[7.7.3.13,15.17,11]henicosa-1,3(20),7,9,11(21),15-hexaen-2-ol
- 351426-05-6/6,8-Dibromo-4-chloro-2-methylquinazoline
- 1632031-39-0/4,4'-Dimethylaminorex, cis-
- 19052-75-6/2,4b,6,8b-Tetramethyl-4a,4b,8a,8b-tetrahydro-4h,8h-cyclobuta[1,2-b:3,4-b']dipyran-4,8-dione
- 1234616-00-2/3-Bromo-1H-pyrrolo[2,3-B]pyridine-5-carboxylic acid
- 1378667-67-4/[1-(Dimethylamino)cyclobutyl]methanol
- 1217696-35-9/(2R,3R)-3-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)-2-hydroxypropanoic acid
- 1187927-59-8/1,4,4-Trimethyl-1,2,3,4-tetrahydro-quinolin-6-ylamine
- 496842-39-8/(14-~13~C,14,14,14-~2~H_3_)Galanthamine--hydrogen bromide (1/1)
- 1818294-43-7/Azido-PEG9-t-butyl ester
- 1189954-18-4/Lercanidipine-d3 Hydrochloride
- 123629-51-6/1,1,1,2,2,3,3,10,10,11,11,12,12,12-Tetradecafluoro-4,4,9,9-tetrakis(trifluoromethyl)dodecane
- 72236-27-2/N1,N14-Dimethyl-3,6,9,12-tetraoxatetradecane-1,14-diamine
- 882420-21-5/2-(3-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)acetic acid
- 913541-96-5/Cetyl tranexamate hydrochloride
- 400900-00-7/2,4-Difluorophenyl chloroformate
- 46954-71-6/1-(4-Bromophenyl)-[1,3]thiazolo[2,3-b][1,3]benzothiazol-9-ium
- 1243290-37-0/Tofacitinib metabolite M2
- 1523530-44-0/(R)-Methyl pyrrolidine-3-carboxylate trifluoroacetate
- 1219979-46-0/N,N-Diethyl-3-(3-pyrrolidinyloxy)aniline hydrochloride
- 1220036-02-1/4-[2-Chloro-4-(1-methyl-1-phenylethyl)phenoxy]-piperidine hydrochloride
- 524746-12-1/5-Hydroxydeferasirox
- 66312-01-4/CID 54607306
- 1159826-34-2/2-(2-Aminoethyl)benzonitrile hydrochloride
- 78172-08-4/7,8,9,10-tetrahydro-1H-naphtho[2,3-g]quinoline-2,5,12-trione
- 1261942-26-0/5-(3,5-Dicarboxyphenyl)-3-trifluoromethoxyphenol
- 1332528-44-5/1-(4-Chlorobenzyl)piperazin-2-one hydrochloride
- 1353867-75-0/Toltrazuril-d3